Navigation Links
Up for Debate This Week: National Service, Mental Health Coverage, and Consumer Product Safety
Date:3/3/2008

o improve the screening of

noncompliant consumer products, to improve the effectiveness of consumer

product recall programs, and for other purposes

What People Think: 50% For, 50% Against

http://www.washingtonwatch.com/bills/show/110_SN_2663.html

Displayed below are new, updated, and passed items with their cost or savings per family.

New Items

S. 1921

The Civil War Battlefield Preservation Act of 2007

Costs $0.36 per family

http://www.washingtonwatch.com/bills/show/110_SN_1921.html

H.R. 5159

The Capitol Visitor Center Act of 2008

Costs $1.44 per family

http://www.washingtonwatch.com/bills/show/110_HR_5159.html

H.R. 5351

The Renewable Energy and Energy Conservation Tax Act of 2008

Costs $24.44 per family

http://www.washingtonwatch.com/bills/show/110_HR_5351.html

Updated Items

H.R. 1239

The National Underground Railroad Network to Freedom Reauthorization Act

of 2007

Costs $0.12 per family

http://www.washingtonwatch.com/bills/show/110_HR_1239.html

Passed Items

P.L. 110-189

The Cameron Gulbransen Kids and Cars Safety Act of 2007

http://www.washingtonwatch.com/bills/show/110_PL_110-189.html

P.L. 110-190

The Airport and Airway Extension Act of 2008

http://www.washingtonwatc
'/>"/>

SOURCE WashingtonWatch.com
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mike Huckabee Accepts Values Voter Presidential Debate
2. Democratic Candidates Miss Key Health Issue in Debate
3. 6th Annual Pinot Noir Summit Inspires Passionate Debate
4. In Unfolding Budget Debate, Alliance to Spotlight Flawed MedPAC Policy Guidance, Failure to Evaluate Medicaid Margins in Recommending Medicare Funding Levels
5. PCMA: 2008 Health Debate Highlights Workable Solutions Like E-Prescribing
6. Debate over safety of gene therapy trials focuses on issue of informed consent
7. Engaging 2008 Debate, Key Long Term Care Advocacy Groups Offer New Plan to Strengthen Nations Long Term and Post-Acute Care Delivery System
8. Mayo Clinic Proceedings provides forum for debate about capital punishment
9. Long Term Care Leader Applauds Clinton for Bringing Critical Issue of Senior Care into the Presidential Debate
10. Post-Debate Statement from AARP Board Member Joyce Payne
11. Study fuels debate over whether exercise and body size influence ovarian cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...ewswire/ -- The HealthCentral,Network, Inc. (http...pConnection.com, a new online medical and peer-to-...hose struggling with obesity about,drugs, surgerie...scuss and,post questions., Three expert writers, .... Jeffrey Heit, television health reporter Amy Hen...
(Date:7/9/2008)...n that would cut $39 million from,Medicare Advanta...Newswire-USNewswire/ -- Seniors across,Mississippi...icare,Advantage program in legislation being consi...31) would cut $39 million from the Medicare Advant...back the areas where Medicare,private fee-for-serv...
(Date:7/9/2008)...n that would cut $38 million from,Medicare Advanta...ewswire-USNewswire/ -- Seniors across New Mexico,a...are Advantage program in,legislation being conside...) would cut $38 million from the Medicare Advantag...k the areas where Medicare private,fee-for-service...
(Date:7/9/2008)...a larger role in kidney transplants than previousl... well in men due to their smaller size. Women hav...Therefore, in the future, gender should be conside...esearchers from Basel and Heidelberg. , These re...ve Transplant Study", the world,s largest database...
Breaking Medicine News(10 mins):Health News:Responding to Increased Incidence of Obesity and Associated Health Issues, The HealthCentral Network Launches Site to Support those Struggling with Weight 2Health News:Mississippi Seniors Speak Out Against Medicare Advantage Cuts 2Health News:New Mexico Seniors Speak Out Against Medicare Advantage Cuts 2Health News:Male kidneys for men only? 2
... offered an insight into the 'déjà vu' phenomenon,...ertain things before. // Leeds university research...ct in the memory process. Though all of us have ex...o-day life, for some people, this kind of a feelin...
...om Health Department as introduced new reforms to ...aims at giving better treatment at an affordable /... effective plan is aimed at concentration more at ... Secretary Patricia Hewitt on the new reforms as s...
...nister has promised his countrymen safe drinking w...reforms in governance are being given priority // ... India do not have access to safe drinking water. ...ters in charge of rural drinking water supply and ...
... mostly develops during young adulthood and scient...mood-altering drugs helps them to relieve of their... helps them to overcome the Manic depressive illne...lleagues from Yale’s Mood Disorder Research Progra...
Other Medicine News:Health News:Mystery Behind The Déjà Vu Phenomenon Yet To Be Resolv 2Health News:Safe Drinking Water To Be Made Available 2
(Date:7/8/2008)...K, July 8 /- McGraw-Hill Professional...es for the scientific and medical,communities, tod...ectiveness reference to its comprehensive online p...//www.accesspharmacy.com ). Through an alliance wi...ases generated from clinical,studies, AccessPharma...
(Date:7/7/2008)...HCV Development Presence Includes ANA598 and ANA77...Complementary Mechanisms Conferen...- Anadys Pharmaceuticals,I...suming clinical,investigation of the Toll-Like Rec...nic hepatitis C. Based on preclinical pharmacology...
(Date:7/7/2008)...NG, July 7 /- OrbusNeich today announ...l Meeting of the Japanese Society of,Interventiona...eered R,stent has better outcomes when compared to...ione, M.D., the study,s principal,investigator and...ples,s,Division of Cardiology, Department of Clini...
(Date:7/6/2008)...e basis for CTI,s Marketing Authorization Applicat...by the EMEA, SEATTLE, July 7 /PRNewswire-FirstCal... ; MTA) today announced the publication of results...XIO(TM) (paclitaxel poliglumex,CT-2103) with gemc...performance status 2) patients with previously unt...
Breaking Medicine Technology:McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5Providence Holy Cross Medical Center Ignores Community Environmental Concerns With Planned Expansion of Mission Hills Facility 19133 1Providence Holy Cross Medical Center Ignores Community Environmental Concerns With Planned Expansion of Mission Hills Facility 19133 2Cardinal Health Completes Enturia Acquisition 2043 1Cardinal Health Completes Enturia Acquisition 2043 2Federal government taps NC State experts to explain nanotech risks 5330 1Federal government taps NC State experts to explain nanotech risks 5330 2Westaim announces 2008 first quarter results 19126 1Westaim announces 2008 first quarter results 19126 2Westaim announces 2008 first quarter results 19126 3
... 2007 /PRNewswire/ -- Prolexys,Pharmaceuticals and...erties of the selective small molecule anti-tumor ...company,s,chemi-proteomics technology to understan... to be published in the June 14, 2007 issue,of the...hondrial,voltage- dependent anion channels (VDACs)...
...07 /PRNewswire/ -- Two studies presented,today dem... peak,plasma levels, nor did it impair middle-of-t...n patients who suffer from chronic,insomnia. The r...nnual Meeting of the Associated Professional Sleep...ause they show that ROZEREM may be,a safe sleep me...
Other Medicine Technology:Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 2Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 3Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 2Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 3Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 4Study Demonstrated Rozerem (ramelteon) Does Not Affect,Middle-of-the-Night Balance in Older Adults with Insomnia 5
The Reusable Template is designed for use with the Brachystepper® as a guidance system for prostate brachytherapy. Please be sure that the graphics on your software match the graphics on the Reus
The MicroTouch LP (low profile) is specifically designed for use on cystoscopy tables with a fixed fluoroscopy/x-ray gantry. The MicroTouch LP attaches to tables on the side opposite the gantry and a
The Precision Stepper is the first stepper with a fully adjustable baseline. This new technology permits the physician to fine-tune the depth of the ultrasound transducer for accurate imaging and pr
The specially designed table-mounted stepper/stabilizer offers the strength and stability necessary for a flawless delivery of brachytherapy.
Medicine Products: